Profil
Frank Benesch-Lee was the founder and had worked as a Chief Engineer at Myomics, Inc. which was founded in 2003.
He obtained his undergraduate degree from Technische Hochschule Rosenheim in 2001.
Anciens postes connus de Frank Benesch-Lee
| Sociétés | Poste | Fin |
|---|---|---|
Myomics, Inc.
 Myomics, Inc. Pharmaceuticals: GenericHealth Technology Myomics, Inc. developed drugs to treat neuromuscular disease indications, such as muscle atrophy in the elderly and muscle wasting in chronic illness, included cancer and muscular dystrophy disorders. It had discovery programs based on its two proprietary technology platforms: tissue-engineered muscle, which can be generated in vitro from human and animal models of normal and diseased muscle, and opto-mechanical systems to monitor the ability of candidate compounds to increase the contractile strength of tissue-engineered muscle. The company was founded in 2003 and headquartered in Providence, RI. | Fondateur | - |
Formation de Frank Benesch-Lee
| Technische Hochschule Rosenheim | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Myomics, Inc.
Myomics, Inc. Pharmaceuticals: GenericHealth Technology Myomics, Inc. developed drugs to treat neuromuscular disease indications, such as muscle atrophy in the elderly and muscle wasting in chronic illness, included cancer and muscular dystrophy disorders. It had discovery programs based on its two proprietary technology platforms: tissue-engineered muscle, which can be generated in vitro from human and animal models of normal and diseased muscle, and opto-mechanical systems to monitor the ability of candidate compounds to increase the contractile strength of tissue-engineered muscle. The company was founded in 2003 and headquartered in Providence, RI. | Health Technology |
